Royalty Pharma prices $2B senior notes in three tranches: 2031, 2035, 2055

Royalty Pharma plc

$600M 4.450% notes due 2031, $900M 5.200% notes due 2035, $500M 5.950% notes due 2055.
Notes are senior unsecured and guaranteed by Royalty Pharma Holdings Ltd and RP Manager LLC.
Issuance closed September 16, 2025; interest payments begin March 25, 2026.
Underwriters include BofA, Goldman Sachs, J.P. Morgan, Morgan Stanley, and TD Securities.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.